FTRE
Price
$16.09
Change
-$0.69 (-4.11%)
Updated
Jan 15, 11:32 AM (EDT)
Capitalization
1.55B
60 days until earnings call
Intraday BUY SELL Signals
RAPP
Price
$27.19
Change
-$0.23 (-0.84%)
Updated
Jan 15, 12:03 PM (EDT)
Capitalization
1.31B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FTRE vs RAPP

Header iconFTRE vs RAPP Comparison
Open Charts FTRE vs RAPPBanner chart's image
Fortrea Holdings
Price$16.09
Change-$0.69 (-4.11%)
Volume$7.88K
Capitalization1.55B
Rapport Therapeutics
Price$27.19
Change-$0.23 (-0.84%)
Volume$1K
Capitalization1.31B
FTRE vs RAPP Comparison Chart in %
FTRE
Daily Signal:
Gain/Loss:
RAPP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FTRE vs. RAPP commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (FTRE: $16.77 vs. RAPP: $27.42)
Brand notoriety: FTRE and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 111% vs. RAPP: 82%
Market capitalization -- FTRE: $1.55B vs. RAPP: $1.31B
FTRE [@Biotechnology] is valued at $1.55B. RAPP’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, both FTRE and RAPP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 2 TA indicator(s) are bullish while RAPP’s TA Score has 4 bullish TA indicator(s).

  • FTRE’s TA Score: 2 bullish, 6 bearish.
  • RAPP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а -4.12% price change this week, while RAPP (@Biotechnology) price change was -8.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

FTRE is expected to report earnings on Mar 16, 2026.

RAPP is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.55B) has a higher market cap than RAPP($1.31B). FTRE YTD gains are higher at: -2.783 vs. RAPP (-9.624). RAPP has higher annual earnings (EBITDA): -109.1M vs. FTRE (-852.7M). RAPP has more cash in the bank: 513M vs. FTRE (131M). RAPP has less debt than FTRE: RAPP (11.9M) vs FTRE (1.19B). FTRE has higher revenues than RAPP: FTRE (2.76B) vs RAPP (0).
FTRERAPPFTRE / RAPP
Capitalization1.55B1.31B119%
EBITDA-852.7M-109.1M782%
Gain YTD-2.783-9.62429%
P/E RatioN/A21.80-
Revenue2.76B0-
Total Cash131M513M26%
Total Debt1.19B11.9M9,975%
TECHNICAL ANALYSIS
Technical Analysis
FTRERAPP
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 28 days ago
75%
Bullish Trend 1 day ago
90%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signal:
Gain/Loss:
RAPP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBMX88.610.89
+1.01%
Rydex Basic Materials A
FSLZX48.46N/A
N/A
Fidelity Advisor Stock Selec Mid Cp Z
GGESX25.12-0.14
-0.55%
Nationwide Schroders Global Eq Instl Svc
EGORX19.78-0.18
-0.90%
Allspring Large Cap Core R6
OGLYX89.93-1.14
-1.25%
Invesco Global Y

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-3.45%
BEAM - FTRE
45%
Loosely correlated
+2.49%
SYRE - FTRE
45%
Loosely correlated
+5.17%
TECH - FTRE
43%
Loosely correlated
+3.07%
NTLA - FTRE
41%
Loosely correlated
+2.39%
ALGS - FTRE
40%
Loosely correlated
-2.06%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+1.18%
NEVPF - RAPP
45%
Loosely correlated
N/A
PRAX - RAPP
35%
Loosely correlated
+6.28%
FTRE - RAPP
35%
Loosely correlated
-3.45%
MLTX - RAPP
34%
Loosely correlated
+1.81%
VRDN - RAPP
33%
Poorly correlated
+5.60%
More